LSE:SCLP (Scancell Holdings plc)
About SCLP
Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.
Scancell Holdings plc (LSE: SCLP) Latest News
Investing Articles
Is Scancell the best penny stock for me to buy today?
Investing Articles
Scancell shares are on fire! Should I buy?
Growth Shares
I’d forget RC365 shares! I think these 2 penny stocks could be next
Investing Articles
If I had a spare £1,000 I’d buy this penny stock right now!
Investing Articles
Is the Scancell share price set to rocket in 2023?
Investing Articles
Why is the Scancell share price climbing?
Investing Articles
2 speculative penny stocks I’m thinking about buying
Investing Articles
As the Scancell (SCLP) share price falls, should I buy?
Investing Articles
UK shares: Scancell Holdings and Morses Club soar on fresh news!
Investing Articles
I’d buy this Covid-19-related penny stock
Investing Articles
Top micro-cap stocks for March 2021
Investing Articles
Is Scancell Holdings Plc The Perfect Partner For BTG plc And Shire PLC In Your Portfolio?
1❯